Your browser doesn't support javascript.
loading
A novel GSK-3beta inhibitor reduces Alzheimer's pathology and rescues neuronal loss in vivo.
Serenó, L; Coma, M; Rodríguez, M; Sánchez-Ferrer, P; Sánchez, M B; Gich, I; Agulló, J M; Pérez, M; Avila, J; Guardia-Laguarta, C; Clarimón, J; Lleó, A; Gómez-Isla, T.
Affiliation
  • Serenó L; Departamento de Neurología, Hospital Santa Cruz y San Pablo, Universidad Autónoma de Barcelona, Barcelona, Spain.
Neurobiol Dis ; 35(3): 359-67, 2009 Sep.
Article in En | MEDLINE | ID: mdl-19523516

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Thiadiazoles / Enzyme Inhibitors / Alzheimer Disease / Neurons Limits: Animals / Female / Humans / Male Language: En Journal: Neurobiol Dis Year: 2009 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Thiadiazoles / Enzyme Inhibitors / Alzheimer Disease / Neurons Limits: Animals / Female / Humans / Male Language: En Journal: Neurobiol Dis Year: 2009 Document type: Article